vs

Side-by-side financial comparison of KORU Medical Systems, Inc. (KRMD) and LIGHTPATH TECHNOLOGIES INC (LPTH). Click either name above to swap in a different company.

LIGHTPATH TECHNOLOGIES INC is the larger business by last-quarter revenue ($16.4M vs $10.9M, roughly 1.5× KORU Medical Systems, Inc.). On growth, LIGHTPATH TECHNOLOGIES INC posted the faster year-over-year revenue change (120.2% vs 23.3%). LIGHTPATH TECHNOLOGIES INC produced more free cash flow last quarter ($2.0M vs $687.0K). Over the past eight quarters, LIGHTPATH TECHNOLOGIES INC's revenue compounded faster (45.7% CAGR vs 15.3%).

KORU Medical Systems, Inc. is a specialized medical technology company that designs, manufactures, and distributes innovative ambulatory infusion systems and supporting disposable products. It caters to healthcare providers and patients across home care, clinical trial, and acute care segments worldwide, with a focus on enhancing the safety and comfort of specialty medication delivery.

LightPath Technologies Inc designs, manufactures and distributes high-precision optical components and assemblies, including aspheric lenses, infrared optics, and fiber optic products. It serves global clients across industrial automation, aerospace, defense, medical imaging, and telecommunications sectors.

KRMD vs LPTH — Head-to-Head

Bigger by revenue
LPTH
LPTH
1.5× larger
LPTH
$16.4M
$10.9M
KRMD
Growing faster (revenue YoY)
LPTH
LPTH
+97.0% gap
LPTH
120.2%
23.3%
KRMD
More free cash flow
LPTH
LPTH
$1.3M more FCF
LPTH
$2.0M
$687.0K
KRMD
Faster 2-yr revenue CAGR
LPTH
LPTH
Annualised
LPTH
45.7%
15.3%
KRMD

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
KRMD
KRMD
LPTH
LPTH
Revenue
$10.9M
$16.4M
Net Profit
$-9.4M
Gross Margin
62.6%
36.8%
Operating Margin
-5.0%
-52.6%
Net Margin
-57.5%
Revenue YoY
23.3%
120.2%
Net Profit YoY
-260.1%
EPS (diluted)
$-0.11
$-0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KRMD
KRMD
LPTH
LPTH
Q4 25
$10.9M
$16.4M
Q3 25
$10.4M
$15.1M
Q2 25
$10.2M
$12.2M
Q1 25
$9.6M
$9.2M
Q4 24
$8.8M
$7.4M
Q3 24
$8.2M
$8.4M
Q2 24
$8.4M
$8.6M
Q1 24
$8.2M
$7.7M
Net Profit
KRMD
KRMD
LPTH
LPTH
Q4 25
$-9.4M
Q3 25
$-778.0K
$-2.9M
Q2 25
$-206.9K
$-7.1M
Q1 25
$-1.2M
$-3.6M
Q4 24
$-2.6M
Q3 24
$-1.6M
$-1.6M
Q2 24
$-988.7K
$-2.4M
Q1 24
$-1.9M
$-2.6M
Gross Margin
KRMD
KRMD
LPTH
LPTH
Q4 25
62.6%
36.8%
Q3 25
60.2%
29.8%
Q2 25
63.5%
22.0%
Q1 25
62.8%
29.1%
Q4 24
62.9%
26.0%
Q3 24
63.4%
33.9%
Q2 24
65.0%
29.2%
Q1 24
62.3%
20.9%
Operating Margin
KRMD
KRMD
LPTH
LPTH
Q4 25
-5.0%
-52.6%
Q3 25
-8.3%
-16.6%
Q2 25
-3.1%
-38.0%
Q1 25
-12.9%
-36.3%
Q4 24
-18.0%
-33.5%
Q3 24
-20.8%
-16.4%
Q2 24
-14.1%
-25.6%
Q1 24
-23.9%
-33.6%
Net Margin
KRMD
KRMD
LPTH
LPTH
Q4 25
-57.5%
Q3 25
-7.5%
-19.2%
Q2 25
-2.0%
-57.8%
Q1 25
-12.1%
-39.1%
Q4 24
-35.2%
Q3 24
-19.3%
-19.3%
Q2 24
-11.7%
-27.3%
Q1 24
-23.6%
-33.7%
EPS (diluted)
KRMD
KRMD
LPTH
LPTH
Q4 25
$-0.11
$-0.20
Q3 25
$0.02
$-0.07
Q2 25
$0.00
$0.19
Q1 25
$0.03
$-0.44
Q4 24
$-0.22
$-0.07
Q3 24
$0.03
$-0.04
Q2 24
$0.02
$-0.15
Q1 24
$0.04
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KRMD
KRMD
LPTH
LPTH
Cash + ST InvestmentsLiquidity on hand
$8.9M
$73.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$17.0M
$77.9M
Total Assets
$28.2M
$148.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KRMD
KRMD
LPTH
LPTH
Q4 25
$8.9M
$73.6M
Q3 25
$8.5M
Q2 25
$8.1M
$4.9M
Q1 25
$8.7M
Q4 24
$9.6M
Q3 24
$8.8M
Q2 24
$10.5M
Q1 24
$10.8M
Total Debt
KRMD
KRMD
LPTH
LPTH
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$535.0K
Q1 24
$599.4K
Stockholders' Equity
KRMD
KRMD
LPTH
LPTH
Q4 25
$17.0M
$77.9M
Q3 25
$16.5M
$21.4M
Q2 25
$16.5M
$15.6M
Q1 25
$16.3M
$15.7M
Q4 24
$16.8M
$26.7M
Q3 24
$17.7M
$29.4M
Q2 24
$18.7M
$30.2M
Q1 24
$19.1M
$31.7M
Total Assets
KRMD
KRMD
LPTH
LPTH
Q4 25
$28.2M
$148.6M
Q3 25
$27.1M
$87.3M
Q2 25
$25.5M
$81.5M
Q1 25
$27.2M
$81.4M
Q4 24
$27.2M
$45.8M
Q3 24
$27.4M
$48.4M
Q2 24
$27.3M
$48.1M
Q1 24
$27.5M
$49.7M
Debt / Equity
KRMD
KRMD
LPTH
LPTH
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.02×
Q1 24
0.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KRMD
KRMD
LPTH
LPTH
Operating Cash FlowLast quarter
$1.1M
$2.8M
Free Cash FlowOCF − Capex
$687.0K
$2.0M
FCF MarginFCF / Revenue
6.3%
12.0%
Capex IntensityCapex / Revenue
3.7%
5.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-470.1K
$-6.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KRMD
KRMD
LPTH
LPTH
Q4 25
$1.1M
$2.8M
Q3 25
$65.5K
$-1.1M
Q2 25
$-460.3K
$-2.6M
Q1 25
$-237.5K
$-3.2M
Q4 24
$939.6K
$-737.4K
Q3 24
$-923.9K
$-1.7M
Q2 24
$11.3K
$64.7K
Q1 24
$-346.7K
$-394.2K
Free Cash Flow
KRMD
KRMD
LPTH
LPTH
Q4 25
$687.0K
$2.0M
Q3 25
$13.0K
$-1.2M
Q2 25
$-489.2K
$-3.3M
Q1 25
$-680.9K
$-3.7M
Q4 24
$896.0K
$-817.8K
Q3 24
$-2.0M
$-1.8M
Q2 24
$-112.9K
$-225.5K
Q1 24
$-479.8K
$-802.5K
FCF Margin
KRMD
KRMD
LPTH
LPTH
Q4 25
6.3%
12.0%
Q3 25
0.1%
-8.1%
Q2 25
-4.8%
-27.3%
Q1 25
-7.1%
-40.0%
Q4 24
10.1%
-11.0%
Q3 24
-24.5%
-21.2%
Q2 24
-1.3%
-2.6%
Q1 24
-5.9%
-10.4%
Capex Intensity
KRMD
KRMD
LPTH
LPTH
Q4 25
3.7%
5.3%
Q3 25
0.5%
0.5%
Q2 25
0.3%
5.6%
Q1 25
4.6%
4.6%
Q4 24
0.5%
1.1%
Q3 24
13.2%
0.9%
Q2 24
1.5%
3.4%
Q1 24
1.6%
5.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KRMD
KRMD

US$8.3M76%
Non Us$2.6M24%

LPTH
LPTH

Other$7.9M48%
Infrared Components$5.0M31%
Visible Components$3.4M21%

Related Comparisons